In this study the NRR assay was used to assess the evolution of the lysosomal
membranes integrity during sexual maturation, spawning and postspawning recovery in large and small Pacific oysters.
The occasional absence of lysosomal
membranes around particulates (e.
Malakoplakia: Evidence for monocyte lysosomal
abnormality correctable by cholinergic agonist in vitro and in vivo.
Younkin and his colleagues treated normal nerve cells with chemicals known to block lysosomal
A snapshot of the global therapeutic scenario for Lysosomal
Giving an overview on rare diseases, Medical Director of NIBD Professor Tahir Shamsi said that regardless of the lack of disease registry in Pakistan, more than 100 patients were likely to be affected every year by treatable Lysosomal
Storage Disorders (LSDs).
According to him the estimated combined incidence of all lysosomal
storage disorders was about 1 in 5,000 live births.
NHS National Framework Agreement for the Supply of Homecare Delivery Service Lysosomal
com/prnh/20130307/600769 The term lysosomal
storage diseases refers to a group of rare inherited disorders caused by the deficiency of lysosomal
enzymes, activator proteins, proteins required for normal post-translational modification of lysosomal
enzymes or proteins required for intracellular transport between lysosome and other cellular compartments.
There are 11 known forms of MPS, each involving a different lysosomal
Birmingham Children's Hospital is pioneering use of the first kind of therapy to treat inherited metabolic illnesses, lysosomal
storage disorders, after a drug was created in California.
to jointly develop Amicus' three lead pharmacological chaperone compounds for lysosomal
ABSTRACT Neutral red retention (NRR) assay was used to evaluate the effect of changes in water temperature on lysosomal
membrane integrity in the hemolymph of blacklip abalone, Haliotis rubra.
storage disorders (LSDs) (1) are a group of more than 50 inherited diseases, which have a combined incidence of ~1:7700 live births (1).
Hemophilia B is the first clinical application of our IVPRP which can be applied to many other diseases that are currently treated by protein replacement including hemophilia A and lysosomal
storage disorders," said Geoff Nichol, M.